Inflammatory injury • MicroRNA-146a • C-X-C chemokine receptor type 4 • PI3K/AKT • Wnt/β-catenin Abstract Background/Aims: Osteoarthritis (OA) as a degenerative disease is a major problem in ageing populations. To better understand the molecular mechanisms in the pathogenesis of OA, this study explored the role of microRNA (miR)-146a in the articular chondrocytes. Methods: The articular chondrocyte line ATDC5 was used to simulate inflammatory injury by LPS administration in vitro. Cell viability, apoptosis, mRNA expressions and productions of inflammatory factors were assessed, respectively. Mir-146a and Cxcr4 mRNA expressions were measured by qRT-PCR. Targeting effect of miR-146a on Cxcr4 3'UTR was assessed by luciferase activity analysis. Protein expression levels of CXCR4 and main factors in PI3K/AKT, Wnt/β-catenin signal pathways were measured by western blotting. Results: LPS exposure suppressed cell viability, prompted apoptosis of ATDC5 cells, and stimulated expression and release of inflammatory factors. MiR-146a was upregulated in LPS-induced cells. Overexpression of miR146a further aggravated LPS-induced inflammatory injury, while it was reduced after miR146a was knocked down. CXCR4 expression was negatively regulated by miR-146a. CXCR4 was a direct target of miR-146a and thus involved in regulatory effect of miR-146a on the injured chondrocytes, which was also related with phosphorylation levels of PI3K/AKT and expressions of Wnt/β-catenin signal factors. Conclusion: miR-146a promoted inflammatory response of articular chondrocytes via targeting CXCR4 and suppressing CXCR4 expression. Overexpression of CXCR4 could attenuate the inflammatory injury. Our findings provided novel evidence which might be useful for further studies exploring therapeutic approaches for OA via targeting miR-146a.
MiR-146a Aggravates LPS-Induced

Introduction
Osteoarthritis (OA) is one of the most common joint disorders with no significant ethnic and regional differences [1] . OA is characterized by a progressive degradation of articular leading to loss of joint mobility and function accompanied by chronic pain [2] . The incidence of OA increases with age, and thus becomes a major problem in ageing populations [3] . For decades, OA has been regarded as a pathological condition resulting from the degeneration or destruction of the articular cartilage tissue, in which the extracellular matrix (ECM) served as primary target of articular cartilage [4] . However, this view ignored the involvement of articular chondrocytes, as potential instigator of OA. The articular chondrocytes, which only comprise 2-3% of total cartilage volume, could regulate the fate of articular cartilage by synthesize the structural components of ECM as well as matrix-degrading proteases [5] . Owing to the pivotal role of cartilage cells in OA disease process, the cartilage chondrocyte became the preferred cells in OA researches, and the study of chondrocyte inflammatory injury is of great significance in understanding the pathogenesis and clinical treatment of OA [6] .
MicroRNAs (miRNAs), a class of small non-coding RNAs (about 22 nucleotides), act as an important regulator in gene expression, especially in the post-transcriptional level [7] . A growing number of evidence indicated that miRNAs are involved in the control of various basic cell functions [8] . Studied have indicated that miRNAs have an important role in the process of chondrogenesis and cartilage remodeling [9] . The aberrant miRNA expression profiles have been demonstrated to be associated with OA [10, 11] , and miRNAs acted as important regulators in OA development, as well as participated in inflammatory response [12, 13] . Previous studies have demonstrated that many miRNAs were involved in the regulation of OA, such as miR-320, miR-21, and miR-140 [14] [15] [16] . The miR-146a, as a negative regulator of leukocyte immune response, is involved in many other cell processes including cancer cell proliferation [17, 18] . The expression pattern of miR-146a in cartilage from patients with OA has been identified that miR-146a was intensely expressed in low-grade OA cartilage, suggesting the potential role of miR-146a in OA cartilage pathogenesis [19] . Another investigation indicated that miR-146a could protect cartilage from degeneration in OA, as miR-146a overexpression inhibited hypoxia-induced autophagy in chondrocytes [20] . However the exact role of miR-146a in OA is still unclearly.
The present study aimed to investigate the role of miR-146a in the articular chondrocytes cells which were subjected with LPS to induce inflammatory lesions, and the effect of altered miR-146a expression on the cells proliferation and apoptosis in vitro. In addition, miRNAs negatively regulate gene expression by controlling complementary target mRNAs and prohibiting their translation into functional proteins [21] . Therefore, the present study also investigated the target gene of miR-146a in cartilage chondrocytes cells, and the potential regulating mechanism of miR-146a in OA pathogenesis.
Materials and Methods
Cell culture and administration of LPS
The murine articular chondrocyte line ATDC5 was purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were cultured in Dulbecco's modified eagle medium: Nutrient Mixture F-12 (DMEM/F-12, Thermo Scientific, Rockford, IL, USA) supplemented with 2 mM Glutamine (Sigma-Aldrich, St. Louis, MO, USA) and fetal bovine serum (FBS, HyClone, Logan, UT, USA) which is 10% (v/v) for cell growth; or 2% (v/v) for cell maintaining. The culture medium was changed every 3 days until confluence reached. Stable cells were cultured in a humidified CO 2 (5%) incubator at 37°C.
Stable cultured cells with more than 75% confluence were split at 1:2 by using 0.25% trypsin (Ameresco, Framingham, MA, USA) and been cultured to 80% confluence. The culture medium was replaced with serum-free DMEM/F-12 medium and cells were cultured for another 24 h in a humidified atmosphere with 5% CO 2 at 37°C. The ATDC5 cells were cultured with LPS (Sigma-Aldrich, St. Louis, Mo, USA) in a Cellular Physiology and Biochemistry
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Apoptotic assay
Apoptosis analysis was performed to identify and quantify the apoptotic cells by using Annexin V-FITC/ PI apoptosis detection kit (BD Biosciences, Franklin Lakes, NJ, USA) followed by flow cytometry. Briefly, after LPS treatment as described above, cells were cultured for 48 h and harvested, 1 × 10 6 cells were stained by 5 μL Annexin V-FITC (BD Biosciences) for 20 min at room temperature in the dark. Then, 10 μl PI (5 μg/mL) in 1 × binding buffer was added to each sample for 15 min in the dark. Subsequently, apoptosis in the cells was determined by using FCM (FacSCalibur; Becton-Dickinson, Franklin Lakes, NJ, USA) and Cell Quest software (Becton-Dickinson) to differentiate apoptotic cells (Annexin-V positive and PI-negative) from necrotic cells (Annexin-V and PI-positive). The apoptotic assay was performed in three independent experiments.
Enzyme-linked immunosorbent assay (ELISA) assay
Following treatment of LPS for 48 h as described above, the culture supernatant was collected from 24-well plates and concentrations of inflammatory cytokines, including interleukin (IL)-1β, IL-6, IL-8 and tumor necrosis factor (TNF)-α, were measured by using ELISA kit (R&D Systems, Abingdon, UK) according to the manufacturers protocols. Data were normalized and calculated on the basis of linear calibration curves generated by standard solutions.
Real-time quantitative PCR (qRT-PCR)
Total RNA from administrated cells was extracted using Trizol reagent (Life Technologies Corporation, Carlsbad, CA, USA) according to the manufacturer's instructions and been purified by RNeasy Mini kit (Qiagen, Germany). The extracted RNA samples were reversed by TaqMan® MicroRNA Reverse Transcription Kit (Thermo Fisher Scientific, USA), and TaqMan MicroRNA Assay supplemented with the TaqMan Universal Master Mix II (Applied Biosystems, Foster City, CA, USA) were used for qRT-PCR analysis of miR-146a. For the mRNA measurement, Multiscribe TM Reverse transcription Kit (Applied Biosystems, CA, USA) supplemented with random hexamers or oligo (dT) and Fast START Universal SYBR Green Master (ROX) (Roche, USA) were used for qRT-PCR on the ABI PRISM 7500 Real-time PCR System (Applied Biosystems, Foster City, CA). All primers were obtained from the NCBI GeneBank database and were synthesized by GenePharma (Shanghai, China). The reactions were performed in triplicate for each sample at least three independent runs. Data were analyzed according to the classic 2 -△△Ct method, and normalized to U6 snRNA or Gapdh expression in each sample. The primers used were provided in Table 1 .
Cell transfection
Cells were seeded into six-well plates at 5 × 10 4 per well and incubated for 24 h at 37°C. After grown to 70% confluence, cells were respectively transfected with miR-146a mimic, miR-146a inhibitor, siRNA directly against CXCR4 (siCXCR4), or negative control, that were synthesized by GenePharma Co. (Shanghai, China) for 48 h by using Lipofectamine 3000 reagents (Life Technologies Corporation, Carlsbad, CA, USA) according to the manufacturer's instructions. The stably transfected cells were selected by G418 selection with the culture medium containing 0.5 mg/mL G418 (Sigma-Aldrich, St Louis, MO, USA) for 4 to 5 weeks, and stable cultured clones were isolated and selected [22] . The sequences for mmu-miR-146a mimic and inhibitor were as follows: mimic sense, UGAGAACUGAAUUCCAUGGGUU, mimic anti-sense, CCCAUGGAAUUCAGUUCUCAUU; inhibitor, AACCCAUGGAAUUCAGUUCUCA.
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Dual luciferase activity assay
The constructed pMiR-luciferase report vector (Promega, Madison, WI, USA) with the mmu-CXCR4 3'UTR carrying the putative mmu-miR-146a-binding sites (UUCAGUU) were amplified by PCR referred as CXCR4-wt. To mutate the putative binding site of mmumiR-146a in the mmu-CXCR4 3'UTR, the sequence of putative binding site was replaced to GGGGCGG, and referred as CXCR4-mutated-type (CXCR4-mt). Cells were cotransfected with the reporter constructs or control vectors, and 146a or scramble by using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). Reporter analyses were performed by using the dual-luciferase assay system (Promega, Madison, WI, USA) according to the manufacturer's information.
Western blot assay
The total protein in treated cells was extracted by RIPA lysis buffer (Beyotime Biotechnology, Shanghai, China) supplemented with protease inhibitor (Roche, Guangzhou, China), and then been quantified using BCA™ Protein Assay Kit (Pierce, Appleton, WI, USA). The western blot system was established by using a Bio-Rad Bis-Tris Gel system and polyvinylidene fluoride (PVDF) membranes according to the manufacture's instruction. Primary antibodies were prepared in 5% blocking buffer at a dilution of 1:1000 and incubated with the membranes at 4 C overnight, followed by wash and incubation with secondary antibodies marked by horseradish peroxidase (HRP, ab131368 and ab1575332, Abcam, USA) for 1 h at room temperature. The densitometry of the protein bands was quantified by using Quantity One software (Bio-Rad Laboratories, Inc.) with values expressed relative to GAPDH, the control for the loading and transfer. Western blot analysis was performed using monoclonal primary antibodies: B cell lymphoma 2 (Bcl-2, sc509), Bax (sc20067), pro-Caspase 3 (sc7272), pro-Caspase 9 (sc17784), C-X-C chemokine receptor type 4 (CXCR4, sc6279), Wnt3a (sc80457), Wnt5a (sc365370), (Santa Cruz, USA); Cleaved Caspase 3 (ab2302), Cleaved Caspase 9 (ab2324), protein kinase B (AKT, ab54752), p-AKT (ab38449), phosphatidyl inositide 3-kinases (PI3K, ab86714), p-PI3K (ab182651), β-catenin (ab22656), and GAPDH (ab8245) purchased from Abcam.
Statistical analysis
All data of independent experiments were expressed as mean ± standard deviation (SD). Statistical analyses were performed using Graphpad Prism 6.0 statistical software (GraphPad Software Inc., La Jolla, USA). The P-values were calculated by using a two-way analysis of variance (ANOVA) followed by Bonferroni test (more than two groups) or student's t-test for two groups. P-value of < 0.05 was considered to indicate a statistically significant result.
Results
LPS induced inflammatory response of ATDC5 cells
After administration with different concentrations of LPS (0, 1, 5 and 10 μg/mL), ATDC5 cells viability was assessed and results in Fig. 1A showed that 5 and 10 μg/mL LPS exposure significantly decreased ATDC5 cells viability compare with control groups without LPS administration (P < 0.01 or P < 0.001). Flow cytometry assay results in Fig. 1B showed that the relative apoptotic cell number in LPS treated groups was significantly increased compared 
with that in control group (P < 0.05 for 1 μg/mL LPS administration group, P < 0.01 for 5 μg/mL LPS administration group, and P < 0.001 for 10 μg/mL LPS administration group). Western blot assay in 
(P < 0.01, Fig. 1D ). At the same time, ELISA assay results showed that in LPS administrated groups, the production of inflammatory factors IL-1β (Fig. 1E ), IL-6 (Fig. 1F ), IL-8 ( Fig.  1G ) and TNF-α (Fig. 1H) were all significantly increased compared with control group (P < 0.001), suggesting that LPS effectively induced the upregulation of inflammatory factors and the inflammatory response of ATDC5 cells.
miR-146a promoted LPS-induced inflammatory injury in ATDC5 cells
After LPS administration, qRT-PCR analytical results in Fig. 2A showed that expression of miR-146a was elevated in ATDC5 cells compared with control (P < 0.05). ATDC5 cells were then transfected with miR-146a to assess the effect of miR-146a on LPS-induced inflammatory damage. The qRT-PCR results in Fig. 2B showed that miR-146a mimic transfection significantly increased miR-146a expression level compare with scramble control (P < 0.001); while miR-146a inhibitor transfection decreased miR-146a expression compare with that in the inhibitor control group (P < 0.01), suggesting that miR-146a mimic and miR-146a inhibitor transfections could effectively alter the expression of miR-146a in ATDC5 cells in vitro.
CCK-8 assay results in Fig. 3A showed that LPS administration decreased cell viability of ATDC5 cells. After that, cell viability was decreased in miR-146a mimic transfection group compare with LPS-induced control (P < 0.05), while miR-146a inhibitor transfection increased cell viability compare with inhibitor control (P < 0.05). In Fig. 3B , after that LPS promoted cell apoptosis, miR-146a mimic further increased the number of apoptotic cells (P < 0.05), while miR-146a inhibitor transfection decreased cell apoptosis compared with negative control (P < 0.05). In addition, decreased expression of Bcl-2 by LPS was reduced after miR-146a mimic transfection, and it was increased by miR-146a inhibitor transfection. Expression of Bax, cleaved Caspase 3 and cleaved Caspase 9 were all further increased after miR-146a mimic transfection in LPS-induced cells, while they were all reduced in miR146a inhibitor transfected cells (Fig. 3C) . Meanwhile, mRNA expression levels (Fig. 3D) and productions (Fig. 3E-3H ) of inflammatory factors were all further increased by miR146a mimic transfection compared with the increased expression and production by LPS (P < 0.05). While the increased inflammatory factors expression and productions of these inflammatory factors induced by LPS administration were suppressed by miR-146a inhibitor 
miR-146a directly targeted CXCR4
In ATDC5 cells, after miR-146a transfection, we found that CXCR4 expression was negatively related with miR-146a expression. As shown in Fig. 4A , mRNA expression level of Cxcr4 was significantly decreased in miR-146a mimic transfected group compare with negative control (P < 0.05), while it was increased in miR-146a inhibitor transfected group (P < 0.01). Western blotting results in Fig. 4B showed that miR-146a mimic transfection 
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Cellular Physiology and Biochemistry decreased protein expression of CXCR4, but miR-146a inhibitor transfection increased CXCR4 expression. Dual luciferase activity assay was performed to determine the binding effect of miR-146a on 3'UTR of CXCR4. Results in Fig. 4C showed that co-transfected with miR-146a mimic significantly decreased the luciferase activity of CXCR4-wt group compared with negative control group (P < 0.05). These results suggested that CXCR4 might be a direct target of miR146a in ATDC5 cells and miR-146a negatively regulated the expression of CXCR4.
miR-146a knockdown reduced LPS-induced inflammatory injury via upregulating CXCR4
ATDC5 cells were administrated with LPS and then were transfected with miR-146a inhibitor and/or siCXCR4. Cell viability was assessed and results in Fig. 5A showed that miR-146a inhibitor transfection increased cell viability compare with LPS-induced group (P < 0.05), and co-transfected with siCXCR4 inhibited cell viability which was increased in miR-146a inhibitor transfected group (P < 0.01). In Fig. 5B , the relative apoptotic cells were increased after LPS exposure, and miR-146a inhibitor transfection decreased it (P < 0.05). While in miR-146a inhibitor + siCXCR4 group, the relative number of apoptotic cells was significantly increased compare with miR-146a inhibitor group (P < 0.01). Consistent result was found in Western blot assay as shown in Fig. 5C . In LPS-induced groups, siCXCR4 transfection decreased the expression of Bcl-2, which was decreased by miR-146a inhibitor transfection, and transfection with siCXCR4 increased the expressions of Bax, cleaved Caspase 3 and cleaved Caspase 9, that was decreased after miR-146a inhibitor transfection.
In addition, the mRNA expression levels of inflammatory factors were all increased after siCXCR4 co-transfection compared with miR-146a inhibitor alone (P < 0.05) as shown in Fig.  5D . And also Fig. 5E-5H showed that the productions of inflammatory factors in siCXCR4 transfected group were all significantly increased compared with that was decreased in miR-146a inhibitor transfected groups (P < 0.05, or P < 0.01). Taken together, these results suggested that miR-146a downregulation reduced inflammatory response of ATDC5 cells via upregulating the expression of CXCR4. in miR-146a inhibitor transfected group, suggesting phosphorylation levels of PI3K and AKT were negatively related with miR-146a expression. In Fig. 6B , it showed that the expressions of Wnt3a, Wnt5a and β-Catenin were all decreased in miR-146a mimic transfected group, as well as CXCR4 expression. Meanwhile, in miR-146a inhibitor transfected group, expressions of these factors were all increased, suggesting that the activation of Wnt/β-Catenin signaling pathway and expression of CXCR4 were all negatively related with miR-146a expression in ATDC5 cells in vitro.
Discussion
Over the last decade, there have been great strides in genomic analyses of OA owing to the study of adequately powered patient cohorts, the detailed analysis of candidate genes, and the application of genome-wide approaches [23] . These studies have led to unexpected and exciting discoveries, implicating some potential pathways and factors in this common arthritis. Based on the prior observations that the OA disease is associated with inflammatory, and the inflammatory gene is the OA risk factor that alteration in the expression is so highly relevant to the disease process [24, 25] . Our present studies indicated the key role of miR-146a in the inflammatory injury of chondrocytes, which were induced by LPS to simulate inflammatory model in vitro, with regulatory effect on the activation of PI3K/AKT and Wnt/β-catenin signaling pathways which was mediated by CXCR4. We found that administration of LPS (5 and 10 μg/mL) effectively caused cell inflammatory response, cell viability suppression and apoptosis promotion, suggesting that LPS could effectively induce an in vitro model of articular chondrocyte inflammatory injury.
MiRNAs act as important regulators in modulating and maintaining normal physiological conditions [26] . The levels of miRNA have been proved to be changed in response to pathological disorders, resulting in the pathogenesis of degenerative diseases, such as OA [27, 28] . Therefore, it is important to determine the regulation of miRNA expressions in OA. In this present study, we found that miR-146a was significantly increased in the chondrocytes after LPS exposure. Previous studies have suggested the negatively regulatory effect of miR146a on immune response [29] . It was proved that miR-146a acted as an immunoregulatory 
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Cellular Physiology and Biochemistry miRNA in the innate response in virus infection [30] . The present study hypothesized that miR-146a may be another mediator of inflammatory response in chondrocytes. Transfection of synthetic miR-146a mimic in vitro was found to elevate LPS-induced suppression of ATDC5 cell viability and the increased apoptosis, exacerbated the inflammatory response of chondrocytes including the increased expressions and products of IL-1β, IL-6, IL-8 and TNFα. Our study suggested that miR-146a overexpression might promote inflammatory response of chondrocytes. In the study of Liang et al., it was found that miRNA against CXCR4 to block the invasion and metastasis of breast cancer cells [31] . In the present studies, we found that expression of CXCR4 was negatively regulated by miR-146a. The regulatory effect of miR-146a on the expression of CXCR4 was also been investigated. Besides, dual-luciferase activity assay was performed to investigate the underlying mechanisms of miR-146a and 3'UTR of CXCR4, and CXCR4 was identified as a potential target gene of miR-146a. CXCR4 is an alphachemokine receptor specific for stromal-derived-factor-1 (SDF-1 also called CXCL12), a molecule endowed with potent chemotactic activity for lymphocytes. It has been reported that CXCR4 signaling regulated the expression of CD20 on B cells [32] . Evidence in animal model suggested the ubiquitin was the natural ligand of CXCR4 and it was anti-inflammatory immune modulator and endogenous opponent of pro-inflammatory damage associated molecular pattern molecules [33] , suggesting that CXCR4 was involved in the immune response.
In this present study, we found that CXCR4 was negatively regulated by miR-146a and thus regulated cell inflammatory damages. Western blotting analysis was then used to predict several signaling pathways that possibly contribute to the effect of CXCR4 which was regulated by miR-146a on chondrocytes. Results suggested that CXCR4 as the target of miR-146a was positively related with the activation of PI3K/AKT and Wnt/β-catenin signaling pathways in chondrocytes in vitro. It is well-known that PI3K/AKT signaling plays acritical role in modulating cell survival and apoptosis [34] , and it have been found overactivated in many cancers reducing apoptosis and promoting proliferation [35] . Wnt/β-catenin signaling pathway is important for cell proliferation and differentiation [36] . The activation of PI3K/AKT can activate the Wnt signaling through the phosphorylation of GSK-3β by the phosphorylated Akt1/2, blocking the formation of β-catenin destroying complies [37] . Thus we deduced that miR-146a effect on cell viability and apoptosis of inflammatory chondrocytes might be via regulating CXCR4 expression and PI3K/AKT and Wnt/β-catenin signaling pathways.
Conclusion
The present study demonstrated that miR-146a promoted inflammatory response of articular chondrocytes might be via targeting CXCR4 and deactivating PI3K/AKT and Wnt/ β-catenin pathways. According to these results, we might in fact be close to demonstration at genomic level of OA pathogenesis, that this study preliminary explored the role of miR-146a in the pathogenesis of OA. It must be admitted that more in vivo or animal researches will be helpful to understand the pathogenesis of OA and make miRNAs contribute to clinical treatment of OA. These results might have implication for the design of trials of novel OA interventions, and might also guide the intelligent repurposing of anti-inflammatory therapies.
